Impact of knockout mice in toxicology

Critical Reviews in Toxicology

Volumn 27, Issue 2, 1997, Pages 135-154

  Ryffel, Bernhard ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cytokine; Endotoxic shock; Hemopoiesis; Homologous recombination; Immune system; Inflammation; Knockout mice; Toxicity

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; MEMBRANE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANEMIA; ANIMAL MODEL; AUTOIMMUNITY; BONE MARROW TOXICITY; CONTROLLED STUDY; ETIOLOGY; GENE DELETION; IMMUNE DEFICIENCY; INFLAMMATION; LIVER TOXICITY; MOUSE; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; RECOMBINANT DNA TECHNOLOGY; REVIEW; SEPTIC SHOCK; TOXICOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0030887195     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449709021616     Document Type: Review

References (120)

1. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol., 7, 145, 1989.
2. Grau, G. E., Lambert, P. H., Vassalli, P., and Piguet, P. F., Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology, Int. Rev. Exp. Pathol., 34, 159, 1993.
3. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., and Nagata, S., Human Fas ligand: gene structure, chromosomal location and species specificity, Int. Immunol., 6(10), 1567, 1994.
4. Nagata, S. and Golstein, P., The Fas death factor, Science, 267(5203), 1449, 1995.
5. Nagata, S., Fas and Fas ligand: a death factor and its receptor, Adv. Immunol., 57(129), 129, 1994.
6. Miyawaki, S., Nakamura, Y., Suzuka, H., Koba, M., Yasumizu, R., Ikehara, S., and Shibata, Y., A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice, Eur. J. Immunol., 24(2), 429, 1994.
7. Yeung, R. S., Penninger, J., and Mak, T. W., T-cell development and function in gene-knockout mice, Curr. Opin. Immunol., 6(2), 298, 1994.
8. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H., and Rajewsky, K., Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting [see comments], Science, 265(5168), 103, 1994.
9. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A., and Horak, I., Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting, Nature (London), 352(6336), 621, 1991.
10. Kundig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., and Horak, I., Immune responses in interleukin-2-deficient mice, Science, 262(5136), 1059, 1993.
11. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I., Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene [see comments], Cell, 75(2), 253, 1993.
12. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis [see comments], Cell, 75(2), 263, 1993.
13. Strober, W. and Ehrhardt, R. O., Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice [comment], Cell, 75(2), 203, 1993.
14. DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A., and Rajewsky, K., Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain, Proc. Natl. Acad. Sci. U. S. A., 92(2), 377, 1995.
15. Cao, X., Shores, E., Hu-Li, J., Anver, M., and Keisall, B., Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain, Immunity, 2, 223, 1995.
16. Suzuki, H., Kundig, T., Furlonger, C., Wakeham, A., Taniguchi, T., Page, C., and Mak, T., Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta, Science, 268, 1472, 1995.
17. Kuhn, R., Rajewsky, K., and Muller, W., Generation and analysis of interleukin-4 deficient mice, Science, 254(5032), 707, 1991.
18. Kopf, M., Le-Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H., and Kohler, G., Disruption of the murine IL-4 gene blocks Th2 cytokine responses, Nature (London), 362(6417), 245, 1993.
19. Vajdy, M., Kosco, V. M., Kopf, M., Kohler, G., and Lycke, N., Impaired mucosul immune responses in interleukin 4-targeted mice, J. Exp. Med., 181(1), 41, 1995.
20. Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., and Kishimoto, T., IgG1 plasmacytosis in interleukin 6 transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 86(19), 7547, 1989.
21. Hirota, H., Yoshida, K., Kishimoto, T., and Taga, T., Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice, Proc. Natl. Acad. Sci. U. S. A., 92(11), 4862, 1995.
22. Ryffel, B., Mihatsch, M. J., and Woerly, G., Pathology induced by interleukin-6, Int. Rev. Exp. Pathol., 34, 79, 1993.
23. Ryffel, B., Car, B. D., Woerly, G., Weber, M., DiPadova, F., Kammuller, M., Klug, S., Neubert, R., and Neubert, D., Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate - the marmoset, Blood, 83(8), 2093, 1994.
24. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G., Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature (London), 368(6469), 339, 1994.
25. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., and Poli, V., Defective inflammatory response in interleukin 6-deficient mice, J. Exp. Med., 180(4), 1243, 1994.
26. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Koehler, G., and Kopf, M., The role of interleukin-6 in mucosal IgA antibody responses in vivo, Science, 264(5158), 561, 1994.
27. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., and Costantini, F., Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, Embo. J., 13(5), 1189, 1994.
28. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., and Kishimoto, T., Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages, Cell, 80(2), 353, 1995.
29. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W. Z., Mori, C., Shiota, K., Yoshida, N., and Kishimoto, T., Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders, Proc. Natl. Acad. Sci. U. S. A., 93(1), 407, 1996.
30. von Freeden Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine, J. Exp. Med., 181(4), 1519, 1995.
31. Trinchieri, G., Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes, Blood, 84(12), 4008, 1994.
32. Brunda, M. J., Interleukin-12, J. Leukoc. Biol., 55(2), 280, 1994.
33. Leonard, W. J., Noguchi, M., Russell, S. M., and McBride, O. W., The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c, Immunol Rev. 138, 61, 1994.
34. Hemmi, S., Peghini, P., Metzler, M., Merlin, G., Dembic, Z., and Aguet, M., Cloning of murine interferon gamma receptor cDNA: expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon gamma, Proc. Natl. Acad. Sci. U. S. A., 86(24), 9901, 1989.
35. Hemmi, S., Bohni, R., Stark, G., Di-Marco, F., and Aguet, M., A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells, Cell, 76(5), 803, 1994.
36. Darnell, J., Jr., Kerr, I. M., and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264(5164), 1415, 1994.
37. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., and Stewart, T. A., Multiple defects of immune cell function in mice with disrupted interferon-gamma genes [see comments], Science, 259(5102), 1739, 1993.
38. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M., and Aguet, M., Immune response in mice that lack the interteron-gamma receptor [see comments], Science, 259(5102), 1742, 1993.
39. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., and Aguet, M., Functional role of type I and type II interferons in antiviral defense, Science, 264(5167), 1918, 1994.
40. Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., et al., Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis, Science, 264(5159), 713, 1994.
41. Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A., Maher, D. W., Cebon, J., Sinickas, V., and Dunn, A. R., Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, Proc. Natl. Acad. Sci. U. S. A., 91(12), 5592, 1994.
42. Lieschke, G. J., Stanley, E., Grail, D., Hodgson, G., Sinickas, V., Gall, J. A., Sinclair, R. A., and Dunn, A. R., Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease, Blood, 84(1), 27, 1994.
43. Nishinakamura, R., Nakayama, N., Hirabazashi, Y., Araai, K., Miyajima, A., and Murray, R., Mice deficient for the IL-3/GM-CSF/IL-5 beta-c receptor exhibit lung pathology and impaired immune response, while beta-IL-3 receptor deficient mice are normal, Immunity, 2, 211, 1995.
44. de-Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., Darbonne, W. C., Henzel, W. J., Wong, S. C., Kuang, W. J., et al., Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand [see comments], Nature (London), 369(6481), 533, 1994.
45. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J. M., Crimmin, M., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., et al., Matrix metalloproteinases and processing of pro-TNF-alpha, J. Leukocyte Biol., 57(5), 774, 1995.
46. Browning, J. L., Ngam-Ek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brine-Greco, B., Foley, S.F., and Ware, C. F., Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface, Cell, 72(6), 847, 1993.
47. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin, R. G., and Smith, C. A., A lymphotoxin-beta-specific receptor [see comments], Science, 264(5159), 707, 1994.
48. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., and Bluethmann, H., Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes, Nature (London), 364(6440), 798, 1993.
49. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronke, M., and Mak, T. W., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection, Cell, 73(3), 457, 1993.
50. Le Hir, M., Bluethmann, H., Kosco-Vilbois, M. H., Muller, M., di Padova, F., Moore, M., Ryffel, B., and Eugster, H. P., Differentiation of follicular dendritic cells and full antibody responses require TNF receptor-1 signalling, J. Exp. Med., in press, 1996.
51. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C., Schreiber, R. D., Goeddel, D. V., and Moore, M. W., Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice, Nature (London), 372(6506), 560, 1994.
52. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin [see comments], Science, 264(5159), 703, 1994.
53. Banks, T. A., Rouse, B. T., Kerley, M. K., Blair, P. J., Godfrey, V. L., Kuklin, N. K., Bouley, D. M., Thomas, J., Kanangat, S., and Mucenski, M. L., Lymphotoxin-a deficient mice, J. Immunol., 155: 1685, 1995.
54. Matsumoto, M., Nariathasan, S., Hahm, M. H., Peschon, J. J., and Chaplin, D. D., Role of lymphotoxin and type I TNF receptor in the formation of germinal centers, Science, 271, 1289, 1996.
55. Eugster, H. P., Muller, M., Karrer, U., Car, B. D., Schnyder, B., Eng, V. M., Woerly, G., Di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H., and Ryffel, B., Multiple immune abormalities in TNF and LTa double deficient mice, It Immunol., 8(1), 23, 1996.
56. Muller, M., Eugster, H. P., Le Hir, M., Shakhov, A., Di Padova, F., Maurer, C., Quesniaux, V. J. F., and Ryffel, B., Correction and transfer of immunodeficiency of TMF-LT deficiency by bone marrow transplantation, Mol. Med., 2, 247, 1996.
57. Renshaw, B. R., Fanslow, W. R., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., and Maliszewski, C. R., Humoral immune responses in CD40 ligand-deficient mice, J. Exp. Med., 180(5), 1889, 1994.
58. Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., and Geha, R. S., CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation, Proc. Natl. Acad. Sci. U. S. A., 91(25), 12135, 1994.
59. Gordon, J., Katira, A., Holder, M., MacDonald, I., and Pound, J., Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens, Cell. Mol. Biol., 1(1), 1, 1994.
60. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell, 76(6), 969, 1994.
61. Zheng, H., Fletcher, D., Kozak, W., Hofmann, K. J. J., Tocci, M. J., and Ploegh, V. D., Resistance to fever induction and impaired acute-phase response in interleukin-1b-deficient mice, Immunity, 3, 9, 1995.
62. Kuida, K., Lippke, J., Ku, G., Harding, M., Livingston, D., and Su, M., Altered cytokine export and apoptosis in mice deficient in interleukin-1beta converting enzyme, Science, 267, 2000, 1995.
63. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J. et al., Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock, Cell, 80(3), 401, 1995.
64. Kulkarni, A. B. and Karlsson, S., Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease, Am. J. Pathol., 143(1), 3, 1993.
65. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al., Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease, Nature (London), 359(6397), 693, 1992.
66. Wei, X., Charles, I., Smith, A., Ure, J., and Feng, G., Altered immune response in mice lacking inducible nitric oxide synthase, Nature (London), 375, 408, 1995.
67. MacMicking, J., Nathan, D., Horn, D., Chartrain, N., and Fletscher, D., Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase, Cell, 81, 641, 1995.
68. Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H., and Fishman, M. C., Targeted disruption of the neuronal nitric oxide synthase gene, Cell, 75(7), 1273, 1993.
69. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., and Moskowitz, M. A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science, 265(5180), 1883, 1994.
70. Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., Kontgen, F., and Abbondanzo, S. J., Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor [see comments], Nature (London), 359(6390), 76, 1992.
71. Escary, J. L., Perreau, J., Dumenil, D., Ezine, S., and Brulet, P., Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation, Nature (London), 363(6427), 361, 1993.
72. Springer, T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76(2), 301, 1994.
73. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O., and Wagner, D. D., Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice, Cell, 74(3), 541, 1993.
74. Subramaniam, M., Saffaripour, S., Watson, S., Mayadas, T., and Hynes, R., Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-Selectin-deficient mice, J. Exp. Med., 181, 2277, 1995.
75. Tedder, T., Steeber, D., and Pizcueta, P., L-Selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites, J. Exp. Med., 181, 2259, 1995.
76. Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., Wood, W. I., and Moore, M. W., Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog, Science, 265(5172), 682, 1994.
77. Xu, H., Gonzalo, J. A., St. Pierre, Y., Williams, I. R., Kupper, T. S., Cotran, R. S., Springer, T. A., and Gutierrez-Ramos, J. C., Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice, J. Exp. Med., 180(1), 95, 1994.
78. Bullard, D., Qin, L., Lorenzo, I., Quinlin, W., and Doyle, W., P-Selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli, J. Clin. Invest., 95, 1782-1995.
79. Krege, J., John, S., Langenbach, L., Hodgin, J., Hagaman, J., and Bachman, E., Male-female differences in fertility and blood pressure in ACE-deficient mice, Nature (London), 375, 146, 1995.
80. Smit, J. J., Schinkel, A. H., Mol, C. A., Majoor, D., Mooi, W. J., Jongsma, A. P., Lincke, C. R., and Borst, P., Tissue distribution of the human MDR3 P-glycoprotein [see comments], Lab. Invest., 71(5), 638, 1994.
81. Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van derValk, M. A., Robanus-Maandag, E. C., te Riele, H. P., et al., Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, 77(4), 491, 1994.
82. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C., Scatter factor/hepatocyte growth factor is essential for liver development, Nature (London), 373(6516), 699, 1995.
83. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N., Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor, Nature (London), 373(6516), 702, 1995.
84. Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al., Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 [see comments], Nature (London), 372(6502), 182, 1994.
85. Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B. R., Johnson, R. S., and Kahn, C. R., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene [see comments], Nature (London), 372(6502), 186, 1994.
86. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E, Science, 258(5081), 468, 1992.
87. Ishibashi, S., Brown, M.S., Goldstein, J.L., Gerard, R. D., Hammer, R. E., and Herz, J., Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments], J. Clin. Invest., 92(2), 883, 1993.
88. Chen, X. S., Sheller, J. R., Johnson, E. N., and Funk, C. D., Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene, Nature (London), 372(6502), 179, 1994.
89. Goulet, J. L., Snouwaert, J. N., Latour, A. M., Coffman, T. M., and Koller, B. H., Altered inflammatory responses in leukotriene-deficient mice, Proc. Natl. Acad. Sci. U. S. A., 91(26), 12852, 1994.
90. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al., Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83(3), 473, 1995.
91. Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al., Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83(3), 483, 1995.
92. Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al., Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature (London), 378(6555), 406, 1995.
93. Grigoriadis, A. E., Schellander, K., Wang, Z. Q., and Wagner, E. F., Osteoblasts are target cells for transformation in c-fos transgenic mice, J. Cell. Biol., 122(3), 685, 1993.
94. Wang, Z. Q., Ovitt, C., Grigoriadis, A. E., Mohle-Steinlein, U., Ruther, U., and Wagner, E. F., Bone and haematopoietic defects in mice lacking c-fos, Nature (London), 360(6406), 741, 1992.
95. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J., Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair, Cell, 75(2), 229, 1993.
96. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C., Jr., Butel, J. S., and Bradley, A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature (London), 356(6366), 215, 1992.
97. Kemp, C. J., Donehower, L. A., Bradley, A., and Balmain, A., Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors, Cell, 74(5), 813, 1993.
98. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A., Effects of an Rb mutation in the mouse [see comments], Nature (London), 359(6393), 295, 1992.
99. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H., and Bradley, A., Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments], Nature (London), 359(6393), 288, 1992.
100. Dombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H., and Kinet, J. P., Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene, Cell, 75(5), 969, 1993.
101. Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J. V., FcR gamma chain deletion results in pleiotrophic effector cell defects, Cell, 76(3), 519, 1994.
102. Yu, P., Kosco, V. M., Richards, M., Kohler, G., and Lamers, M. C., Negative feedback regulation of IgE synthesis by murine CD23, Nature (London), 369(6483), 753, 1994.
103. Oettgen, H. C., Martin, T. R., Wynshaw-Boris, A., Deng, C., Drazen, J. M., and Leder, P., Active anaphylaxis in IgE-deficient mice, Nature (London), 370(6488), 367, 1994.
104. Tracey, K. J. and Cerami, A., Tumor necrosis factor: a pleiotropic cytokine and therapeutic target, Annu. Rev. Med., 45, 491, 1994.
105. Garcia, I., Miyazaki, Y., Araki, K., Araki, M., Lucas, R., Grau, G. E., Milon, G., Belkaid, Y., Montixi, C., Lesslauer, W., et al., Transgenic mice expressing high levels of soluble TNF-RI fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections, Eur. J. Immunol., 25(8), 2401, 1995.
106. Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N., and Levitzki, A., Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors, Science, 264(5163), 1319, 1994.
107. Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., and Ryffel, B., Interferon gamma receptor deficient mice are resistant to endotoxic shock, J. Exp. Med., 179(5), 1437, 1994.
108. Baumann, H. and Gauldie, J., The acute phase response, Immunol. Today, 15(2), 74, 1994.
109. Car, B. D., Schnyder, B., Aguet, M., and Ryffel, B., Role of interferon gamma in interleukin 12 induced pathology, Am. J. Pathol., in press, 1995.
110. Eng, V. M., Car, B. D., Schnyder, B., Lorenz, M., Lugli, S., Anderson, T. A., Huang, S., Aguet, M., Ryffel, B., and Quesniaux, V. F., The stimuatory effects of interleukin-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo, J. Exp. Med., 181(5), 1893, 1995.
111. Fernandez-Salguero, P., Pineau, T., Hubert, D., McPhail, T., and Lee, S., Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor, Science, 268, 722, 1995.
112. Le Hir, M., Su, Q., Weber, L., Woerly, G., Granelli Piperno, A., and Ryffel, B., In situ detection of cyclosporin A: evidence for nuclear localization of cyclosporine and cyclophilins, Lab. Invest., 73(5), 727, 1995.
113. Ryffel, B., Cyclosporin binding proteins. Identification, distribution, function and relation to FK binding proteins, Biochem. Pharmacol., 46(1), 1, 1993.
114. Kopf, M., personal communication.
115. Magram, et al., in preparation.
116. Grau, G. E., et al., in preparation.
117. Blüthmann, H., personal communication.
118. Labaud, et al., in preparation.
119. Weber, L. and Ryffel, B., in preparation.
120. Gonzales, et al., in preparation.